Kanaly Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$27K Sell
229
-166
-42% -$18.5K 0.01% 381
2016
Q3
$41K Sell
395
-392
-50% -$42.4K 0.01% 302
2016
Q2
$78K Buy
787
+31
+4% +$3.21K 0.02% 238
2016
Q1
$76K Sell
756
-79
-9% -$8.13K 0.02% 234
2015
Q4
$100K Sell
835
-156
-16% -$18K 0.02% 211
2015
Q3
$107K Buy
991
+75
+8% +$9.31K 0.02% 201
2015
Q2
$106K Buy
916
+615
+204% +$70.3K 0.02% 208
2015
Q1
$35K Sell
301
-6,650
-96% -$795K 0.01% 323
2014
Q4
$778K Sell
6,951
-244
-3% -$25.7K 0.16% 71
2014
Q3
$682K Sell
7,195
-2,771
-28% -$250K 0.13% 83
2014
Q2
$856K Buy
9,966
+7,084
+246% +$539K 0.16% 80
2014
Q1
$201K Buy
2,882
+296
+11% +$23.4K 0.04% 184
2013
Q4
$218K Buy
+2,586
New +$205K 0.04% 182

Other funds holding CELG

Kanaly Trust's CELG Position: Q4 2016 in Review

Kanaly Trust reduced its Celgene Corp (CELG) stake by 42% in Q4 2016, selling an estimated $18.5K and leaving 229 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #381.

Kanaly Trust first reported a position in CELG in Q4 2013 and has held it in 13 quarters since. The position peaked at $856K in Q2 2014. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Kanaly Trust held 229 shares of Celgene Corp worth $27K as of Q4 2016.
  • Kanaly Trust sold 166 Celgene Corp shares in Q4 2016, an estimated $18.5K.
  • Celgene Corp made up 0.01% of Kanaly Trust's portfolio in Q4 2016, its #381 holding.
  • Kanaly Trust first reported a position in Celgene Corp in Q4 2013 and has held it in 13 quarters since.
  • Kanaly Trust's Celgene Corp position peaked at $856K in Q2 2014.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.